PURIPEG
Dead / Cancelled — Cancelled — Section 8 (as of 23 Aug 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76975918
- Registration number
- 2813977
- Mark type
- Word mark
- Filed
- 10 Sept 2001
- Published for opposition
- 02 Jul 2002
- Registered
- 10 Feb 2004
- Next maintenance due
- 10 Feb 2014
- Attorney of record
- Jeffrey L. Van Hoosear
Goods and services
- Class 001 — Chemicals: chemical products for use in industry and science, namely, artificial and synthetic resins, plastics in the form of powders, liquids and pastes for use in manufacturing and in scientific and medical research; chemicals for use in the manufacture of adhesive substances; adjuvants for use in the manufacture of pharmaceuticals; polypeptides and monoclonal antibodies for scientific and research use; chemical additives for use in the manufacture of pharmaceuticals
Owner
- Mountain View Pharmaceuticals, Inc., Menlo Park, CA, US
- Mountain View Pharmaceuticals, Inc., Menlo Park, CA, US
- Mountain View Pharmaceuticals, Inc., Menlo Park, CA, US
Prosecution history
- 23 Aug 2024 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 10 Feb 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Feb 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Feb 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 15 Feb 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Feb 2014 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 15 Feb 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Feb 2014 — TEAS SECTION 8 & 9 RECEIVED
- 09 Mar 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Mar 2009 — ASSIGNED TO PARALEGAL
- 25 Feb 2009 — TEAS SECTION 8 & 15 RECEIVED
- 10 Feb 2004 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2003 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Oct 2003 — ASSIGNED TO EXAMINER
- 29 Aug 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE